The stability of carbidopa in solution.
Pappert
E J
EJ
Department of Neurological Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, USA.
Lipton
J W
JW
Goetz
C G
CG
Ling
Z D
ZD
Stebbins
G T
GT
Carvey
P M
PM
D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000737:chemistry* / Q000592:standards; D002230:Carbidopa / Q000008:administration & dosage / Q000737:chemistry* / Q000592:standards; D004338:Drug Combinations; D004355:Drug Stability; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000737:chemistry*; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics; D010300:Parkinson Disease / Q000188:drug therapy*; D012996:Solutions
D000978:Antiparkinson Agents; D004338:Drug Combinations; D004791:Enzyme Inhibitors; D012996:Solutions; D007980:Levodopa; D002230:Carbidopa